Results 41 to 50 of about 265,748 (319)

Identification of group B respiratory syncytial viruses that lack the 60-nucleotide duplication after six consecutive epidemics of total BA dominance at coastal Kenya [PDF]

open access: yes, 2013
Respiratory syncytial virus BA genotype has reportedly replaced other group B genotypes worldwide. We report the observation of three group B viruses, all identical in G sequence but lacking the BA duplication, at a coastal district hospital in Kenya in ...
Agoti, Charles N.   +4 more
core   +1 more source

Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis

open access: yesThe Lancet, 2010
Summary Background The global burden of disease attributable to respiratory syncytial virus (RSV) remains unknown. We aimed to estimate the global incidence of and mortality from episodes of acute lower respiratory infection (ALRI) due to RSV in children
H. Nair   +20 more
semanticscholar   +1 more source

During the COVID‐19 pandemic where has respiratory syncytial virus gone?

open access: yesPediatric Pulmonology, 2021
The diffusion of the SARS‐CoV‐2 virus and the implementation of restrictive measures led to a drastic reduction of respiratory syncytial virus (RSV) diffusion. Few RSV cases have been detected worldwide, even after the removal of the restrictions.
G. di Mattia   +6 more
semanticscholar   +1 more source

First report of two consecutive respiratory syncytial virus outbreaks by the novel genotypes ON‐1 and NA‐2 in a neonatal intensive care unit

open access: yesJornal de Pediatria (Versão em Português), 2020
Objective: Respiratory syncytial virus is a pathogen frequently involved in nosocomial outbreaks. Although several studies have reported nosocomial outbreaks in neonatal intensive care units, molecular epidemiology data are scarce.
Daniella Gregoria Bomfim Prado da Silva   +12 more
doaj   +3 more sources

The Future of Respiratory Syncytial Virus Disease Prevention and Treatment

open access: yesInfectious Disease and Therapy, 2021
Respiratory syncytial virus (RSV) is a major cause of respiratory tract infections in infants, young children, and older or immunocompromised adults.
J. Domachowske   +2 more
semanticscholar   +1 more source

Urgent Hospitalizations Related to Viral Respiratory Disease in Children during Autumn and Winter Seasons 2022/2023

open access: yesViruses, 2023
Aim: The loosening of social distancing measures over the past two years has led to a resurgence of seasonal epidemics associated with respiratory viral infections in children.
Francesca Peri   +7 more
doaj   +1 more source

4′-Fluorouridine is an oral antiviral that blocks respiratory syncytial virus and SARS-CoV-2 replication

open access: yesScience, 2021
Description Preparing antiviral defenses Antiviral drugs are an important tool in the battle against COVID-19. Both remdesivir and molnupiravir, which target the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) polymerase, were first ...
Julien Sourimant   +14 more
semanticscholar   +1 more source

Genetic relatedness of infecting and reinfecting respiratory syncytial virus strains identified in a birth cohort from rural Kenya [PDF]

open access: yes, 2012
Background: Respiratory syncytial virus (RSV) reinfects individuals repeatedly. The extent to which this is a consequence of RSV antigenic diversity is unclear.
Alexander G. Mwihuri   +50 more
core   +1 more source

Current State of Respiratory Syncytial Virus Disease and Management

open access: yesInfectious Disease and Therapy, 2021
Respiratory syncytial virus (RSV) is a major cause of hospitalizations due to pneumonia and bronchiolitis. Substantial morbidity and socioeconomic burden are associated with RSV infection worldwide.
A. Chatterjee, K. Mavunda, L. Krilov
semanticscholar   +1 more source

The natural history of respiratory syncytial virus in a birth cohort: the influence of age and previous infection on reinfection and disease. [PDF]

open access: yes, 2012
This study aimed to quantify the effect of age, time since last infection, and infection history on the rate of respiratory syncytial virus infection and the effect of age and infection history on the risk of respiratory syncytial virus disease.
Bottomley, C   +7 more
core   +2 more sources

Home - About - Disclaimer - Privacy